Pre-Market News Buzz on: DexCom, Inc.(NASDAQ:DXCM), WestRock Co(NYSE:WRK), Quest Diagnostics Inc(NYSE:DGX), Humana Inc(NYSE:HUM)

Pre-Market News Buzz on: DexCom, Inc.(NASDAQ:DXCM), WestRock Co(NYSE:WRK), Quest Diagnostics Inc(NYSE:DGX), Humana Inc(NYSE:HUM)

- in Business & Finance
0

On Monday, DexCom, Inc. (NASDAQ:DXCM)’s shares declined -5.02% to $85.49.

DexCom, Inc. (DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, declared recently that it has reached a contract with the life sciences team at Google to jointly develop a series of next-generation CGM products that are designed to be smaller and less expensive than existing technologies. These new products will incorporate Google’s miniaturized electronics platform with DexCom’s best-in-class sensor technology. This partnership also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care.

DexCom retains all sales and distribution rights of the products developed under this agreement. DexCom is also obligated to pay an initial upfront payment and milestone payments during development, and revenue-based royalties once these products are launched and have achieved a certain level of revenue.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line comprises DexCom G4 system, a continuous glucose monitoring system; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring.

WestRock Co (NYSE:WRK)’s shares dropped -4.32% to $56.46.

WestRock Company (WRK) declared that D. Michael Wilson will be the chief executive officer of the company’s specialty chemicals business that is predictable to become a publicly traded company, Ingevity, early next year as a result of a spin-off from WestRock. He will join the company on September 1, 2015.

WestRock Company manufactures and sells paper and packaging solutions for consumer and corrugated markets in North America, South America, Europe, and the Asia-Pacific. It offers folding cartons for use in various food and non-food applications; superior pumps, sprayers, and dispensing closures for home cleaning, healthcare, and beauty and personal care products; and corrugated containers for home appliances, electric motors, small machinery, produce, books, furniture, and other products.

At the end of Monday’s trade, Quest Diagnostics Inc (NYSE:DGX)‘s shares dipped -4.06% to $67.37.

Quest Diagnostics (DGX), the world’s leading provider of diagnostic information services, declared that its Board of Directors declared a quarterly cash dividend of $0.38 per share, payable on October 21, 2015 to shareholders of record of Quest Diagnostics common stock on October 6, 2015.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, in addition to related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; analytic, on-site prevention, and wellness services; and risk assessment services for the life insurance industry.

Humana Inc (NYSE:HUM), ended its Monday’s trading session with -3.44% loss, and closed at $175.47.

Premier Health, the largest health system in Southwest Ohio, and Humana Inc. (HUM), one of the country’s leading health and well-being companies, declared that they have teamed up on a new value-based agreement that will focus on improving health and wellness for about 30,000 Medicare Advantage members in the Miami Valley.

The value-based agreement reflects a shift away from the current episodic health care model to a value-based model that emphasizes quality and patient care experiences. The accountable care approach aligns Premier Health’s and Humana’s complimentary population health capabilities, counting predictive analytics, chronic disease administration and wellness programs.

Humana’s growing Medicare Advantage population throughout Southwest Ohio will have access to Premier Health’s leading network of integrated primary care and specialty physicians, hospitals, health centers, and outpatient centers at over 100 sites of service.

Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

Leave a Reply

Your email address will not be published. Required fields are marked *